Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This commentary explores whether there is epistemic injustice in global antimicrobial resistance (AMR) research - who sets priorities, who produces knowledge, and which types of knowledge are valued. We argue that epistemic injustice may have created blind spots in policy. Addressing this requires a commitment to diversity, equity, and inclusion.

More information Original publication

DOI

10.1016/j.tim.2025.02.005

Type

Other

Publication Date

2025-06-01T00:00:00+00:00

Volume

33

Pages

577 - 579

Total pages

2

Keywords

antimicrobial resistance, diversity, epistemic injustice, equity, ethics, inclusion, Humans, Global Health, Anti-Bacterial Agents, Knowledge, Drug Resistance, Bacterial, World Health Organization, Biomedical Research, Drug Resistance, Microbial